Aspirin Reduces Liver Fat in Clinical Trial of the Most Common Cause of Chronic Liver Disease
Results warrant additional studies into the health benefits of aspirin for patients with metabolic dysfunction–associated steatotic liver disease.
Division of Nephrology
Contact Information
Thier Research Building 1051
50 Blossom Street
Boston,
MA
02114
Phone: 617-643-2888
Email: eprhee@partners.org
Our laboratory is jointly supported by the Nephrology and Endocrinology Divisions of the Department of Medicine. Our laboratory is focused on: 1.) elucidation of a kidney-bone signaling axis that controls systemic phosphate homeostasis, 2.) characterization of other novel kidney anabolic functions that contribute to chronic kidney disease (CKD) pathophysiology, 3.) discovery of CKD biomarkers in well-characterized clinical cohorts, and 4.) multi-omic integration. These studies span epidemiologic applications of metabolomics and proteomics, physiologic investigation in small human cohorts, and mechanistic investigation in model systems.
Kim WD, Deik A, Gonzalez C, Gonzalez ME, Fu F, Ferrari M, Churchhouse CL, Florez JC, Jacobs SBR, Clish CB, Rhee EP. Polyunsaturated Fatty Acid Desaturation is a Mechanism for Glycolytic NAD+ Recycling. Cell Metab 2019; 29(4):856-870.
Simic P, Kim WD, Zhou W, Pierce KA, Chang W, Sykes DB, Aziz NB, Elmariah S, Ngo D, Pajevic PD, Govea N, Kestenbaum BR, de Boer IH, Cheng Z, Christov M, Chun J, Leaf DE, Waikar SS, Tager AM, Gerszten RE, Thadhani RI, Clish CB, Jüppner H, Wein MW, Rhee EP. Glycerol-3-phosphate is a FGF23 regulator derived from the injured kidney. J Clin Invest 2020; 130(3):1513-1526.
Ngo D, Wen D, Gao Y, Keyes MJ, Drury ER, Katz DH, Benson MD, Sinha S, Shen D, Farrell LA, Peterson BD, Friedman DJ, Elmariah S, Young BA, Smith JG, Yang Q, Vasan RS, Larson MG, Correa A, Humphreys BD, Wang TJ, Pollak MR, Wilson JG, Gerszten RE, Rhee EP. Circulating testican-2 is a podocyte-derived marker of kidney health. Proc Natl Acad Sci U.S.A. 2020;117(40):25026-25035.
Wen D, Zheng Z, Surapaneni A, Yu B, Zhou L, Zhou W, Xie D, Shou H, Pacheco JA, Kalim S, He J, Hsu CY, Parsa A, Rao P, Sondheimer J, Townsend R, Waikar SS, Rebholz CM, Denburg MR, Kimmel PL, Vasan RS, Clish CB, Coresh J, Feldman HI, Grams ME, Rhee EP; CKD Biomarkers Consortium and the CRIC Study Investigators. Metabolite Profiling of CKD Progression in the Chronic Renal Insufficiency Cohort Study. JCI Insight 2022; 7(20):e161696.
Wen D, Zhou L, Zheng Z, Surapaneni A, Ballantyne CM, Hoogeveen RC, Shlipak MG, Waikar SS, Vasan RS, Kimmel PL, Dubin RF, Deo R, Feldman HI, Ganz P, Coresh J, Grams ME, Rhee EP; CKD Biomarkers Consortium. Testican-2 is Associated with Reduced Risk of Incident ESKD. J Am Soc Nephrol 2023; 34(1):122-131.
Zhou W, Simic P, Zhou IY, Caravan P, Parada XV, Wen D, Washington OL, Shvedova M, Pierce KA, Clish CB, Mannstadt M, Kobayashi Y, Wein MN, Jüppner H, Rhee EP. Kidney glycolysis serves as a mammalian phosphate sensor that maintains phosphate homeostasis. J Clin Invest 2023; 133(8):e164610.
Every day, our clinicians and scientists chart new terrain in biomedical research to treat and prevent human disease and advance patient care.
Your support of Nephrology helps us provide the best possible care today and expand what will be possible tomorrow.
We offer innovative, high-quality medical care, trains future medical leaders, and produces research that advances science and improves care.
Results warrant additional studies into the health benefits of aspirin for patients with metabolic dysfunction–associated steatotic liver disease.
Researchers have identified numerous genetic clusters that may help explain why people with type 2 diabetes have different clinical presentations.
We reached out to investigators at Massachusetts General Hospital and asked them to give us one science-backed action people can take to improve their heart health.
In a nationally representative of US adults with self-reported chronic liver disease (CLD), approximately 308,000 (6%) identified delaying medical care due to transportation barriers.
In this 12-month, placebo-controlled, randomized clinical trial of 26 well-treated persons with HIV without known CVD, eplerenone was associated with a significant reduction in arterial inflammation.
Blocking reductive stress in the liver may benefit people with conditions such as obesity and fatty liver disease.
The Division of Nephrology at Massachusetts General Hospital is a leading provider of services for patients with kidney disease, including diagnosis and management of kidney diseases and medical management of renal transplantation.